A plan that regulators announced last month will allow patients in Australia legal access to the psychoactive drugs MDMA and psilocybin. Patients will be charged thousands to access the treatment, as there is no source approved for the drug. The Therapeutic Goods Administration, Australia’s medical and therapeutic regulatory agency, , announced last month that licensed…
An activist group for psychedelics has created a committee to lobby Congress in support of research on the therapeutic uses of compounds such as MDMA, ketamine and psilocybin. The Psychedelic Medical PAC is a new organization that aims to lobby Congress to relax restrictions on powerful drugs. These drugs have been shown to be effective…
Vermont lawmakers have introduced several bills that aim to make major changes in the state’s drug laws. The website Psychedelic Spotlight offers a primer about the four pieces of legislation which would “decriminalize all drug possession, increase harm reduction services and remove criminal penalties when using or selling psilocybin, and decriminalize certain psychedelic herbs and…
A pair of Democratic state senators in Nevada introduced a bill last week to allow for research into psilocybin, or psychedelic mushrooms, as well as MDMA, drawing inspiration from states like Oregon and Colorado where such substances have been legalized. The proposal, per the measure’s official legislative summary, would establish “procedures for a research facility…
On March 7, four legislators declared that they had resubmitted their bill on psychedelic treatment. Rep. Nancy Mace (Rep. Madeleine Dean, Sen. Cory Booker and Sen. Rand Paul presented the Breakthrough Therapies Act. This updated bill would amend the Controlled Substances Act and allow medical patients to have access to MDMA or psilocybin. Breakthrough therapies…
